Methyldigoxin

Methyldigoxin is a cardiac glycoside derived from digoxin, used mainly in the treatment of congestive heart failure and certain supraventricular arrhythmias (notably atrial fibrillation). It is grouped under the following drug class(es): Glycosides. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include metildigossina and tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one. Its PubChem CID is 443946.

CAS No 30685-43-9
Molecular Formula C42H66O14
Molecular Weight 795.00g/mol
Synonyms 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

Frequently Asked Questions